The continuing saga of MRSA.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 18422431)

Published in J Infect Dis on May 01, 2008

Authors

Neil Flynn1, Stuart H Cohen

Author Affiliations

1: Department of Internal Medicine, University of California, Davis.

Articles by these authors

Amphotericin B: time for a new "gold standard". Clin Infect Dis (2003) 4.01

Anti-CD20 (rituximab) therapy for anti-IFN-γ autoantibody-associated nontuberculous mycobacterial infection. Blood (2012) 1.68

Comparisons of community-associated methicillin-resistant Staphylococcus aureus (MRSA) and hospital-associated MSRA infections in Sacramento, California. J Clin Microbiol (2006) 1.65

Molecular analysis of Clostridium difficile strains isolated from 18 cases of recurrent clostridium difficile-associated diarrhea. J Clin Microbiol (2003) 1.19

Nosocomial diarrhea: evaluation and treatment of causes other than Clostridium difficile. Clin Infect Dis (2012) 1.11

Spatial and temporal analysis of Clostridium difficile infection in patients at a pediatric hospital in California. Infect Control Hosp Epidemiol (2005) 1.11

Evaluation of Clostridium difficile fecal load and limit of detection during a prospective comparison of two molecular tests, the illumigene C. difficile and Xpert C. difficile/Epi tests. J Clin Microbiol (2012) 1.07

Outcomes in patients tested for Clostridium difficile toxins. Diagn Microbiol Infect Dis (2012) 1.03

Epidemiologic surveillance of Clostridium difficile diarrhea in a freestanding pediatric hospital and a pediatric hospital at a university medical center. Diagn Microbiol Infect Dis (2006) 0.96

Fluoride excess in coccidioidomycosis patients receiving long-term antifungal therapy: an assessment of currently available triazoles. Antimicrob Agents Chemother (2011) 0.94

Prevalence and association of macrolide-lincosamide-streptogramin B (MLS(B)) resistance with resistance to moxifloxacin in Clostridium difficile. J Antimicrob Chemother (2003) 0.94

Early treatment with fluconazole may abrogate the development of IgG antibodies in coccidioidomycosis. Clin Infect Dis (2011) 0.91

Treatments for hepatitis B. Clin Infect Dis (2004) 0.88

Derivation and validation of a clinical prediction score for isolation of inpatients with suspected pulmonary tuberculosis. Infect Control Hosp Epidemiol (2008) 0.86

Clindamycin resistant strains of Clostridium difficile isolated from cases of C. difficile associated diarrhea (CDAD) in a hospital in Sweden. Diagn Microbiol Infect Dis (2002) 0.85

Hepatic mucormycosis with abscess formation. Diagn Microbiol Infect Dis (2012) 0.85

Isolation of non-toxigenic strains of Clostridium difficile from cases of diarrhea among patients hospitalized in hematology/oncology ward. Pol J Microbiol (2004) 0.83

Analysis of Clostridium difficile-associated diarrhea among patients hospitalized in tertiary care academic hospital. Diagn Microbiol Infect Dis (2005) 0.83

Serum (1->3)-β-D-glucan measurement in coccidioidomycosis. J Clin Microbiol (2012) 0.83

Injecting drug use and community-associated methicillin-resistant Staphylococcus aureus infection. Diagn Microbiol Infect Dis (2008) 0.83

Prevalence of the ermB gene in Clostridium difficile strains isolated at a university teaching hospital from 1987 through 1998. Clin Infect Dis (2005) 0.78

Association between serum 25-hydroxyvitamin D level and type of coccidioidal infection. Med Mycol (2012) 0.77

Coccidioidomycosis: adenosine deaminase levels, serologic parameters, culture results, and polymerase chain reaction testing in pleural fluid. Chest (2013) 0.75

Treatment of cytomegalovirus retinitis with cytomegalovirus-specific T-lymphocyte infusion. Ophthalmic Surg Lasers Imaging Retina (2015) 0.75

Teaching neuroimages: fungus in the brain: coccidioidomycosis meningoencephalitis. Neurology (2013) 0.75

Cutaneous manifestations of infection in returning travelers. Curr Infect Dis Rep (2014) 0.75